Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7

Autor:	Mahboob Alam, Dhruv Mahtta, Chayakrit Krittanawong, Michelle T. Lee, Richard S. Schofield, Julia M. Akeroyd, Salim S. Virani, Kirk N. Garratt, Christie M. Ballantyne, Preetika Sinh, David Ramsey, Safi U. Khan, Laura A. Petersen
Rok vydání:	2021
Předmět:	0301 basic medicine Pharmacology medicine.medical_specialty Aspirin Statin Prasugrel medicine.drug_class business.industry Psychological intervention General Medicine 030204 cardiovascular system & hematology Clopidogrel 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Internal medicine medicine Pharmacology (medical) cardiovascular diseases Ticlopidine Medical prescription Cardiology and Cardiovascular Medicine business Ticagrelor medicine.drug
Zdroj:	Cardiovascular Drugs and Therapy. 36:93-102
ISSN:	1573-7241 0920-3206
DOI:	10.1007/s10557-020-07125-3
Popis:	We investigated facility-level variation in the use and adherence with antiplatelets and statins among patients with premature and extremely premature ASCVD. Using the 2014–2015 nationwide Veterans wIth premaTure AtheroscLerosis (VITAL) registry, we assessed patients with premature (age at first ASCVD event: males
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a8378ccb8e8be347d7a5672dcfb63fef https://doi.org/10.1007/s10557-020-07125-3 Zobrazit plný text záznamu Full text from SpringerLink